{
    "organizations": [],
    "uuid": "f676860aa0b0d2fc4ec975441295aae591e7435b",
    "author": "Dana Mattioli",
    "url": "https://www.wsj.com/articles/acorda-therapeutics-exploring-a-potential-sale-1515184331",
    "ord_in_thread": 0,
    "title": "Acorda Therapeutics Exploring a Potential Sale",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Biotechnology company Acorda Therapeutics Inc. is exploring a potential sale, according to people familiar with the matter.\nThe Ardsley, N.Y., maker of medicines for patients with neurological disorders is working with investment bankers from Centerview Partners and MTS Health Partners, the people said.\nThe proceedings are at an early stage... ",
    "published": "2018-01-05T23:35:00.000+02:00",
    "crawled": "2018-01-05T23:57:08.038+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "biotechnology",
        "company",
        "acorda",
        "therapeutic",
        "exploring",
        "potential",
        "sale",
        "according",
        "people",
        "familiar",
        "matter",
        "ardsley",
        "maker",
        "medicine",
        "patient",
        "neurological",
        "disorder",
        "working",
        "investment",
        "banker",
        "centerview",
        "partner",
        "mt",
        "health",
        "partner",
        "people",
        "said",
        "proceeding",
        "early",
        "stage"
    ]
}